WCM-Q research reveals metabolic processes underpinning type 2 diabetes, complications

WCM-Q research reveals metabolic processes underpinning type 2 diabetes, complications

Researchers at Weill Cornell Medicine-Qatar (WCM-Q) have identified metabolites associated with type 2 diabetes and its complications, mainly obesity, retinopathy and dyslipidemia

Smoking can cause Type 2 diabetes, says HMC experts

Smoking can cause Type 2 diabetes, says HMC experts

Smokers are more likely to develop type 2 diabetes than non-smokers, according to Dr Ahmad al-Mulla, head of Hamad Medical Corporation’s (HMC) Tobacco Control Centre.

Qatari study: Type 2 diabetes can be reversed through lifestyle changes

Qatari study: Type 2 diabetes can be reversed through lifestyle changes

A new study by researchers in Qatar has shown that Type 2 diabetes can be reversed with dietary and lifestyle changes.

WCM-Q research links proteins to diabetes

WCM-Q research links proteins to diabetes

Researchers at Weill Cornell Medicine-Qatar (WCM-Q) and the University of Iceland have identified a group of proteins involved in causing type 2 diabetes in humans.

Over 300 Type 2 diabetic patients in Qatar complete Desmond programme

Over 300 Type 2 diabetic patients in Qatar complete Desmond programme

A type 2 diabetes management programme developed by researchers from the UK’s University of Leicester and adapted for Qatar by a team of diabetes educators from Hamad Medical Corporation’s (HMC)

At least one in four Qataris will have diabetes by 2050

At least one in four Qataris will have diabetes by 2050

Researchers at Weill Cornell Medicine-Qatar (WCM-Q) predict that type 2 diabetes prevalence in Qatar will soar from 17% in 2012 to at least 24% by 2050.

Breastfeeding women can lower breast and ovarian cancer risk

Breastfeeding women can lower breast and ovarian cancer risk

Research studies confirm that women who breastfeed their babies for six months or longer can reduce the risk of developing pre- and post-menopausal breast cancer, ovarian cancer, hypertension, and Type 2 diabetes.

National Obesity Treatment Center helping prevent Type 2 diabetes

National Obesity Treatment Center helping prevent Type 2 diabetes

Obesity, a major risk factor for Type 2 diabetes, is being treated at Hamad Medical Corporation’s (HMC) National Obesity Treatment Center through a unique bariatric and weight management service.

High blood pressure patients 'face lower death risk'

High blood pressure patients 'face lower death risk'

Patients with both type 2 diabetes and acute heart failure face a significantly lower risk of death but a higher risk of heart failure-related hospitalisation if they have had high systolic blood pressure on discharge from the hospital.